<?xml version="1.0" encoding="UTF-8"?>
<p>The CRISPR-associated protein 9 (Cas9) system (CRISPR/Cas9) is a revolutionary gene-editing toolbox that can modify target genes with high precision and that can control various types of genetic diseases in preclinical studies [
 <xref rid="B53" ref-type="bibr">53</xref>â€“
 <xref rid="B56" ref-type="bibr">56</xref>]. Due to the collateral nucleic acid cleavage activity of Cas effectors, CRISPR/Cas systems have also been widely used in nucleic acid detection with fluorescent and colorimetric signals [
 <xref rid="B56" ref-type="bibr">56</xref>]. There are mainly two kinds of CRISPR/Cas systems for diagnostics, based on the cutting activity of Cas protein on nucleic acids outside of the gRNA target site: the CRISPR/Cas13a and CRISPR/Cas12a systems.
</p>
